References Kim W, Egan JM
This guide covers everything researchers need to know about alternating between these two GLP-1 receptor agonists, including the science behind why some people consider it, the practical challenges involved, dose conversion protocols , safety considerations, and alternative strategies for those who have hit a plateau
Proc Natl Acad Sci USA 96: 3149, 1999 257 Byun D, Mohan S, Yoo M et al: Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4(IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro
However, absorption rates may vary slightly between sites
Do you have a question about Mounjaro, Ozempic or weight loss
MOTS-c has emerging preclinical + early clinical